ES

Evan Seigerman

#1162 out of 1699 analysts
BMO Capital
Automatically Tracked
Tracking: 0 Updated: Jun 15 at 02:16 PM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
-1.55%
Gain +0.07%
Monthly
0.94%
Yearly
11.84%
Drawdown
41.85%
$206,101.34
Equity
Holdings
$0
Cash
$206,101.34
Investment
$0
$99,767.38
Profit +$151.92
Realized
$99,767.38
Unrealized
$0
Dividends
$1,239.17
$206,101.34
Cash
Deposits
$106,333.96
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0.07%
Profit
$151.92
Win %
100%
This Week
Compared To Last Week
Gain
5.93%
Profit
$11,532.3
Win %
100%
This Month
Compared to last month
Gain
-2.44%
Profit
-$5,157.38
Win %
50%
This Year
Compared to last year
Gain
16.58%
Profit
$29,310.29
Win %
60%
Disc Medicine Inc. logo
IRON Disc Medicine Inc.
+$99,155.72
Vertex Pharmaceuticals Incorporated logo
VRTX Vertex Pharmaceuticals Incorporated
+$48,661.11
Replimune Group Inc. logo
REPL Replimune Group Inc.
+$21,484.31
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
+$15,888.55
Gilead Sciences Inc. logo
GILD Gilead Sciences Inc.
+$7,327.87
Macrogenics Inc. logo
MGNX Macrogenics Inc.
+$4,014.96
Amgen Inc. logo
AMGN Amgen Inc.
+$443.21
Incyte Corporation logo
INCY Incyte Corporation
-$38,524.81
Biogen Inc. logo
BIIB Biogen Inc.
-$30,254.38
Candel Therapeutics Inc. logo
CADL Candel Therapeutics Inc.
-$15,426.22
AcelRx Pharmaceuticals Inc logo
ACRX AcelRx Pharmaceuticals Inc
-$13,002.94
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
116
Longs Won
58/101 57%
Profit Factor
1.52
Profitability
Shorts Won
1/15 6%
Standard Deviation
$9,465.7
Average Win
$4,869.44
Best Trade
(Sep 20) $64,502.65
Sharpe Ratio
-43.05
Average Loss
-$3,311.73
Worst Trade
(May 31) -$49,385.18
Z-Score
-1.21 (77.46%)
Commissions
$0
Avg. Trade Length
2m 2w 6d
Expectancy
$860.06
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% 0.01% 0.2% 0.95% 2.9% 6.86% 13.88% 25.19% 42.21% 66.55%
Consecutive Losing Trades 62 56 50 44 37 31 25 19 12 6
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV